{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T01:08:38Z","timestamp":1788570518671,"version":"build-2803163510"},"reference-count":116,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2005,11,1]],"date-time":"2005-11-01T00:00:00Z","timestamp":1130803200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics"],"published-print":{"date-parts":[[2005,11]]},"DOI":"10.1016\/j.bbapap.2005.08.014","type":"journal-article","created":{"date-parts":[[2005,9,3]],"date-time":"2005-09-03T07:14:26Z","timestamp":1125731666000},"page":"11-22","source":"Crossref","is-referenced-by-count":214,"title":["Clinical aspects of systemic amyloid diseases"],"prefix":"10.1016","volume":"1753","author":[{"given":"Laura","family":"Obici","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vittorio","family":"Perfetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Palladini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Remigio","family":"Moratti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giampaolo","family":"Merlini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbapap.2005.08.014_bib1","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1056\/NEJMra023144","article-title":"Molecular mechanisms of amyloidosis","volume":"349","author":"Merlini","year":"2003","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bbapap.2005.08.014_bib2","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1182\/blood.V79.7.1817.1817","article-title":"Incidence and natural history of primary systemic amyloidosis in Olmsted County, Minnesota, 1950 through 1989","volume":"79","author":"Kyle","year":"1992","journal-title":"Blood"},{"key":"10.1016\/j.bbapap.2005.08.014_bib3","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1046\/j.1365-2141.1998.01034.x","article-title":"Chromosomal abnormalities in systemic amyloidosis","volume":"103","author":"Fonseca","year":"1998","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.bbapap.2005.08.014_bib4","doi-asserted-by":"crossref","first-page":"2266","DOI":"10.1182\/blood.V98.7.2266","article-title":"Translocations involving the immunoglobulin heavy-chain locus are possible early genetic events in patients with primary systemic amyloidosis","volume":"98","author":"Hayman","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.bbapap.2005.08.014_bib5","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1016\/S0002-9440(10)64115-6","article-title":"Translocation T(4;14)(p16.3;q32) is a recurrent genetic lesion in primary amyloidosis","volume":"158","author":"Perfetti","year":"2001","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.bbapap.2005.08.014_bib6","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1182\/blood-2004-04-1424","article-title":"Functional gene expression analysis of clonal plasma cells identifies a unique molecular profile for light chain amyloidosis","volume":"105","author":"Abraham","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.bbapap.2005.08.014_bib7","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1182\/blood.V98.3.714","article-title":"The tropism of organ involvement in primary systemic amyloidosis: contributions of Ig V(L) germ line gene use and clonal plasma cell burden","volume":"98","author":"Comenzo","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.bbapap.2005.08.014_bib8","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1182\/blood-2002-01-0114","article-title":"Merlini G, Analysis of V(lambda)\u2013J(lambda) expression in plasma cells from primary (AL) amyloidosis and normal bone marrow identifies 3r (lambdaIII) as a new amyloid-associated germline gene segment","volume":"100","author":"Perfetti","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.bbapap.2005.08.014_bib9","doi-asserted-by":"crossref","first-page":"3801","DOI":"10.1182\/blood-2002-09-2707","article-title":"Immunoglobulin light chain variable (V) region genes influence clinical presentation and outcome in light chain-associated amyloidosis (AL)","volume":"101","author":"Abraham","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.bbapap.2005.08.014_bib10","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1006\/jsbi.2000.4248","article-title":"Review: immunoglobulin light chain amyloidosis\u2014The archetype of structural and pathogenic variability","volume":"130","author":"Bellotti","year":"2000","journal-title":"J. Struct. Biol."},{"key":"10.1016\/j.bbapap.2005.08.014_bib11","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1110\/ps.8.3.509","article-title":"Physicochemical consequences of amino acid variations that contribute to fibril formation by immunoglobulin light chains","volume":"8","author":"Raffen","year":"1999","journal-title":"Protein Sci."},{"key":"10.1016\/j.bbapap.2005.08.014_bib12","doi-asserted-by":"crossref","first-page":"200","DOI":"10.3109\/13506120009146835","article-title":"Four structural risk factors identify most fibril-forming kappa light chains","volume":"7","author":"Stevens","year":"2000","journal-title":"Amyloid"},{"key":"10.1016\/j.bbapap.2005.08.014_bib13","doi-asserted-by":"crossref","first-page":"5446","DOI":"10.1073\/pnas.91.12.5446","article-title":"A role for destabilizing amino acid replacements in light-chain amyloidosis","volume":"91","author":"Hurle","year":"1994","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.bbapap.2005.08.014_bib14","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S0925-4439(96)00049-X","article-title":"Structural and functional characterization of three human immunoglobulin kappa light chains with different pathological implications","volume":"1317","author":"Bellotti","year":"1996","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bbapap.2005.08.014_bib15","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1002\/jmr.681","article-title":"Structural basis of light chain amyloidogenicity: comparison of the thermodynamic properties, fibrillogenic potential and tertiary structural features of four Vlambda6 proteins","volume":"17","author":"Wall","year":"2004","journal-title":"J. Mol. Recognit."},{"key":"10.1016\/j.bbapap.2005.08.014_bib16","doi-asserted-by":"crossref","first-page":"2948","DOI":"10.1182\/blood.V91.8.2948.2948_2948_2954","article-title":"Evidence that amyloidogenic light chains undergo antigen-driven selection","volume":"91","author":"Perfetti","year":"1998","journal-title":"Blood"},{"key":"10.1016\/j.bbapap.2005.08.014_bib17","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1023\/B:JOCI.0000029113.68758.9f","article-title":"Analysis of somatic hypermutation and antigenic selection in the clonal B cell in immunoglobulin light chain amyloidosis (AL)","volume":"24","author":"Abraham","year":"2004","journal-title":"J. Clin. Immunol."},{"key":"10.1016\/j.bbapap.2005.08.014_bib18","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1002\/1099-1352(200007\/08)13:4<198::AID-JMR499>3.0.CO;2-D","article-title":"Binding of nascent collagen by amyloidogenic light chains and amyloid fibrillogenesis in monolayers of human fibrocytes","volume":"13","author":"Harris","year":"2000","journal-title":"J. Mol. Recognit."},{"key":"10.1016\/j.bbapap.2005.08.014_bib19","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1038\/labinvest.3700069","article-title":"Different types of glomerulopathic light chains interact with mesangial cells using a common receptor but exhibit different intracellular trafficking patterns","volume":"84","author":"Teng","year":"2004","journal-title":"Lab. Invest."},{"key":"10.1016\/j.bbapap.2005.08.014_bib20","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1038\/labinvest.3700161","article-title":"AL-amyloidosis and light-chain deposition disease light chains induce divergent phenotypic transformations of human mesangial cells","volume":"84","author":"Keeling","year":"2004","journal-title":"Lab. Invest."},{"key":"10.1016\/j.bbapap.2005.08.014_bib21","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1007\/PL00000706","article-title":"Immunoglobulin light chains, glycosaminoglycans, and amyloid","volume":"57","author":"Stevens","year":"2000","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.bbapap.2005.08.014_bib22","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1038\/76216","article-title":"Receptor-dependent cell stress and amyloid accumulation in systemic amyloidoses","volume":"6","author":"Yan","year":"2000","journal-title":"Nat. Med."},{"key":"10.1016\/j.bbapap.2005.08.014_bib23","first-page":"45","article-title":"Primary systemic amyloidosis: clinical and laboratory features in 474 cases","volume":"8","author":"Kyle","year":"1995","journal-title":"Semin. Hematol."},{"key":"10.1016\/j.bbapap.2005.08.014_bib24","doi-asserted-by":"crossref","first-page":"4276","DOI":"10.1182\/blood.V99.12.4276","article-title":"Autologous stem cell transplantation for primary systemic amyloidosis","volume":"99","author":"Comenzo","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.bbapap.2005.08.014_bib25","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1016\/S0140-6736(03)13396-X","article-title":"Survival in patients with primary systemic amyloidosis and raised serum cardiac troponins","volume":"361","author":"Dispenzieri","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.bbapap.2005.08.014_bib26","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1182\/blood-2004-01-0390","article-title":"Prognostication of survival using cardiac troponins and N-terminal pro-brain natriuretic peptide in patients with primary systemic amyloidosis undergoing peripheral blood stem cell transplantation","volume":"104","author":"Dispenzieri","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.bbapap.2005.08.014_bib27","doi-asserted-by":"crossref","first-page":"2440","DOI":"10.1161\/01.CIR.0000068314.02595.B2","article-title":"Serum N-terminal pro Brain Natriuretic Peptide is a sensitive marker of myocardial dysfunction in AL amyloidosis","volume":"107","author":"Palladini","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.bbapap.2005.08.014_bib28","doi-asserted-by":"crossref","first-page":"3751","DOI":"10.1200\/JCO.2004.03.029","article-title":"Serum cardiac troponins and N-terminal pro-brain natriuretic peptide: a staging system for primary systemic amyloidosis","volume":"22","author":"Dispenzieri","year":"2004","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.bbapap.2005.08.014_bib29","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1373\/49.8.1337","article-title":"Utility of the amino-terminal fragment of pro-brain natriuretic peptide in plasma for the evaluation of cardiac dysfunction in elderly patients in primary health care","volume":"49","author":"Alehagen","year":"2003","journal-title":"Clin. Chem."},{"key":"10.1016\/j.bbapap.2005.08.014_bib30","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1373\/clinchem.2003.030692","article-title":"Elimination of the cardiac natriuretic peptides B-type natriuretic peptide (BNP) and N-terminal proBNP by hemodialysis","volume":"50","author":"Wahl","year":"2004","journal-title":"Clin. Chem."},{"key":"10.1016\/j.bbapap.2005.08.014_bib31","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1136\/hrt.78.1.74","article-title":"Familial and primary (AL) cardiac amyloidosis: echocardiographically similar diseases with distinctly different clinical outcomes","volume":"78","author":"Dubrey","year":"1997","journal-title":"Heart"},{"key":"10.1016\/j.bbapap.2005.08.014_bib32","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1161\/circ.104.14.1594","article-title":"Infusion of light chains from patients with cardiac amyloidosis causes diastolic dysfunction in isolated mouse hearts","volume":"104","author":"Liao","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.bbapap.2005.08.014_bib33","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1097\/00005792-199107000-00002","article-title":"Secondary systemic amyloidosis: response and survival in 64 patients","volume":"70","author":"Gertz","year":"1991","journal-title":"Medicine"},{"key":"10.1016\/j.bbapap.2005.08.014_bib34","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/S0950-3579(05)80121-9","article-title":"Clinical and therapeutic aspects of AA amyloidosis","volume":"8","author":"Hazenberg","year":"1994","journal-title":"Bailliere's Clin. Rheumatol."},{"key":"10.1016\/j.bbapap.2005.08.014_bib35","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1093\/rheumatology\/keh157","article-title":"Clinical and genetic aspects of the hereditary periodic fever syndromes","volume":"43","author":"Grateau","year":"2004","journal-title":"Rheumatology"},{"key":"10.1016\/j.bbapap.2005.08.014_bib36","doi-asserted-by":"crossref","first-page":"2966","DOI":"10.1002\/art.20490","article-title":"First report of systemic reactive (AA) amyloidosis in a patient with the hyperimmunoglobulinemia D with periodic fever syndrome","volume":"50","author":"Obici","year":"2004","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.bbapap.2005.08.014_bib37","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/s00428-001-0582-9","article-title":"Pathology, diagnosis and pathogenesis of AA amyloidosis","volume":"440","author":"Rocken","year":"2002","journal-title":"Virchows Arch."},{"key":"10.1016\/j.bbapap.2005.08.014_bib38","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1515\/CCLM.1999.063","article-title":"Serum amyloid A (SAA). A concise review of biology, assay methods and clinical usefulness","volume":"37","author":"Yamada","year":"1999","journal-title":"Clin. Chem. Lab. Med."},{"key":"10.1016\/j.bbapap.2005.08.014_bib39","doi-asserted-by":"crossref","first-page":"67","DOI":"10.3109\/13506129908993291","article-title":"Revised nomenclature for serum amyloid A (SAA)","volume":"6","author":"Sipe","year":"1999","journal-title":"Amyloid"},{"key":"10.1016\/j.bbapap.2005.08.014_bib40","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1002\/art.10944","article-title":"The contribution of genotypes at the MEFV and SAA1 loci to amyloidosis and disease severity in patients with Familial Mediterranean fever","volume":"48","author":"Gershoni-Baruch","year":"2003","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.bbapap.2005.08.014_bib41","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1007\/s004390051115","article-title":"Influence of genotypes at SAA1 and SAA2 loci on the development and the length of latent period of secondary AA-amyloidosis in patients with rheumatoid arthritis","volume":"105","author":"Moriguchi","year":"1999","journal-title":"Hum. Genet."},{"key":"10.1016\/j.bbapap.2005.08.014_bib42","doi-asserted-by":"crossref","first-page":"7172","DOI":"10.1074\/jbc.274.11.7172","article-title":"The heparin\/heparan sulfate-binding site on apo-serum amyloid A: implications for the therapeutic intervention of amyloidosis","volume":"274","author":"Ancsin","year":"1999","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbapap.2005.08.014_bib43","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1096\/fj.03-1436fje","article-title":"Amyloidogenesis recapitulated in cell culture. A peptide inhibitor provides direct evidence for the role of heparan sulfate and suggests a new treatment strategy","volume":"18","author":"Elimova","year":"2004","journal-title":"FASEB J."},{"key":"10.1016\/j.bbapap.2005.08.014_bib44","doi-asserted-by":"crossref","first-page":"6473","DOI":"10.1073\/pnas.0502287102","article-title":"In vivo fragmentation of heparan sulfate by heparanase overexpression renders mice resistant to amyloid protein A amyloidosis","volume":"102","author":"Li","year":"2005","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.bbapap.2005.08.014_bib45","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1038\/nm0295-143","article-title":"Arresting amyloidosis in vivo using small molecule anionic sulphonates or sulphates: implications for Alzheimer's disease","volume":"1","author":"Kisilevsky","year":"1995","journal-title":"Nat. Med."},{"key":"10.1016\/j.bbapap.2005.08.014_bib46","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1097\/00041552-200211000-00013","article-title":"Serum amyloid P component scintigraphy for diagnosis and monitoring amyloidosis","volume":"11","author":"Hawkins","year":"2002","journal-title":"Curr. Opin. Nephrol. Hypertens."},{"key":"10.1016\/j.bbapap.2005.08.014_bib47","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1093\/qjmed\/93.8.535","article-title":"Presentation, survival and prognostic markers in AA amyloidosis","volume":"93","author":"Joss","year":"2000","journal-title":"Q. J. Med."},{"key":"10.1016\/j.bbapap.2005.08.014_bib48","series-title":"Amyloid and Amyloidosis","first-page":"173","article-title":"Characteristic and clinical outcome of 340 patients with systemic AA amyloidosis","author":"Lachmann","year":"2005"},{"key":"10.1016\/j.bbapap.2005.08.014_bib49","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/S0140-6736(00)05252-1","article-title":"Amyloid load and clinical outcome in AA amyloidosis in relation to circulating concentration of serum amyloid A protein","volume":"358","author":"Gillmore","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.bbapap.2005.08.014_bib50","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1016\/j.berh.2003.09.001","article-title":"The hereditary amyloidoses","volume":"17","author":"Benson","year":"2003","journal-title":"Best Pract. Res. Clin. Rheumatol."},{"key":"10.1016\/j.bbapap.2005.08.014_bib51","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1038\/385787a0","article-title":"Instability, unfolding and aggregation of human lysozyme variants underlying amyloid fibrillogenesis","volume":"385","author":"Booth","year":"1997","journal-title":"Nature"},{"key":"10.1016\/j.bbapap.2005.08.014_bib52","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/0006-291X(86)90475-4","article-title":"Hereditary cerebral amyloid angiopathy: the amyloid fibrils contain a protein which is a variant of cystatin C, an inhibitor of lysosomal cysteine proteases","volume":"136","author":"Ghiso","year":"1986","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bbapap.2005.08.014_bib53","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1111\/j.1750-3639.2002.tb00449.x","article-title":"Sporadic and familial cerebral amyloid angiopathies","volume":"12","author":"Revesz","year":"2002","journal-title":"Brain Pathol."},{"key":"10.1016\/j.bbapap.2005.08.014_bib54","doi-asserted-by":"crossref","first-page":"32943","DOI":"10.1074\/jbc.274.46.32943","article-title":"The tetrameric protein transthyretin dissociates to a non-native monomer in solution","volume":"274","author":"Quintas","year":"1999","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbapap.2005.08.014_bib55","doi-asserted-by":"crossref","first-page":"16427","DOI":"10.1073\/pnas.202495199","article-title":"Sequence-dependent denaturation energetics: a major determinants in amyloid disease diversity","volume":"99","author":"Hammarstrom","year":"2002","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.bbapap.2005.08.014_bib56","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.cell.2005.01.018","article-title":"The biological and chemical basis for tissue-selective amyloid disease","volume":"121","author":"Sekijima","year":"2005","journal-title":"Cell"},{"key":"10.1016\/j.bbapap.2005.08.014_bib57","first-page":"443","article-title":"Hereditary systemic amyloidosis with renal involvement","volume":"16","author":"Hawkins","year":"2003","journal-title":"J. Nephrol."},{"key":"10.1016\/j.bbapap.2005.08.014_bib58","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1016\/S0002-9440(10)65167-X","article-title":"The new apolipoprotein A-I variant Leu174Ser causes hereditary cardiac amyloidosis, and the amyloid fibrils are constituted by the 93-residue N-terminal polypeptide","volume":"155","author":"Obici","year":"1999","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.bbapap.2005.08.014_bib59","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1053\/j.gastro.2004.03.003","article-title":"Liver biopsy discloses a new apolipoprotein A-I hereditary amyloidosis in several unrelated Italian families","volume":"126","author":"Obici","year":"2004","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bbapap.2005.08.014_bib60","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/S0090-4295(99)00369-6","article-title":"Testicular amyloid deposition as a cause of secondary azoospermia","volume":"55","author":"Schrepferman","year":"2000","journal-title":"Urology"},{"key":"10.1016\/j.bbapap.2005.08.014_bib61","doi-asserted-by":"crossref","first-page":"215","DOI":"10.3109\/13506120309041738","article-title":"Hepatic amyloidosis resulting from deposition of the apolipoprotein A-I variant Leu75Pro","volume":"10","author":"Coriu","year":"2003","journal-title":"Amyloid"},{"key":"10.1016\/j.bbapap.2005.08.014_bib62","doi-asserted-by":"crossref","first-page":"2714","DOI":"10.1172\/JCI118725","article-title":"Hereditary hepatic and systemic amyloidosis caused by a new deletion\/insertion mutation in the apolipoprotein A-I gene","volume":"97","author":"Booth","year":"1996","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbapap.2005.08.014_bib63","series-title":"Amyloid and Amyloidosis","first-page":"312","article-title":"Fibrinogen A \u03b1-chain amyloidosis: clinical features and outcome after hepatorenal or solitary kidney transplantation","author":"Stangou","year":"2005"},{"key":"10.1016\/j.bbapap.2005.08.014_bib64","first-page":"4799","article-title":"Renal amyloidosis with a frame shift mutation in fibrinogen A\u03b1 chain gene producing a novel amyloid protein","volume":"90","author":"Hamidi Asl","year":"1997","journal-title":"Blood"},{"key":"10.1016\/j.bbapap.2005.08.014_bib65","doi-asserted-by":"crossref","first-page":"S45","DOI":"10.1046\/j.1440-1797.8.s.10.x","article-title":"Current clinical and pathogenetic understanding of beta(2)-m amyloidosis in long-term haemodialysis patients","volume":"8","author":"Gejyo","year":"2003","journal-title":"Nephrology"},{"key":"10.1016\/j.bbapap.2005.08.014_bib66","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1093\/ndt\/13.suppl_1.58","article-title":"Dialysis-related amyloidosis","volume":"1","author":"Drueke","year":"1998","journal-title":"Nephrol. Dial. Transplant."},{"key":"10.1016\/j.bbapap.2005.08.014_bib67","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1159\/000183712","article-title":"Pathologic fractures associated with idiopathic amyloidosis of bone in chronic hemodialysis patients","volume":"43","author":"DiRaimondo","year":"1986","journal-title":"Nephron"},{"key":"10.1016\/j.bbapap.2005.08.014_bib68","first-page":"175","article-title":"Tissue distribution of dialysis amyloidosis","volume":"27","author":"Noel","year":"1987","journal-title":"Clin. Nephrol."},{"key":"10.1016\/j.bbapap.2005.08.014_bib69","first-page":"718","article-title":"Systemic distribution of beta 2-microglobulin-derived amyloidosis in patients who undergo long-term hemodialysis. Report of seven cases and review of the literature","volume":"118","author":"Gal","year":"1994","journal-title":"Arch. Pathol. Lab. Med."},{"key":"10.1016\/j.bbapap.2005.08.014_bib70","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1159\/000185699","article-title":"Collagen-binding affinity of beta-2-microglobulin, a preprotein of hemodialysis-associated amyloidosis","volume":"53","author":"Homma","year":"1989","journal-title":"Nephron"},{"key":"10.1016\/j.bbapap.2005.08.014_bib71","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1046\/j.1525-139x.2001.00032.x","article-title":"The role of the synovium and cartilage in the pathogenesis of beta(2)-microglobulin amyloidosis","volume":"14","author":"Moe","year":"2001","journal-title":"Semin. Dial."},{"key":"10.1016\/j.bbapap.2005.08.014_bib72","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1110\/ps.041194005","article-title":"Beta2-microglobulin isoforms display an heterogeneous affinity for type I collagen","volume":"14","author":"Giorgetti","year":"2005","journal-title":"Protein Sci."},{"key":"10.1016\/j.bbapap.2005.08.014_bib73","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1002\/ajh.20381","article-title":"Definition of organ involvement and treatment response in primary systemic amyloidosis (AL): a consensus opinion from the 10th International Symposium on Amyloidosis","volume":"79","author":"Gertz","year":"2005","journal-title":"Am. J. Hematol."},{"key":"10.1016\/j.bbapap.2005.08.014_bib74","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1007\/BF01791147","article-title":"Cardiac and pleuropulmonary AL amyloid imaging with technetium-99m labelled aprotinin","volume":"22","author":"Aprile","year":"1995","journal-title":"Eur. J. Nucl. Med."},{"key":"10.1016\/j.bbapap.2005.08.014_bib75","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1007\/s002590050272","article-title":"Scintigraphic imaging and turnover studies with iodine-131 labelled serum amyloid P component in systemic amyloidosis","volume":"25","author":"Hawkins","year":"1998","journal-title":"Eur. J. Nucl. Med."},{"key":"10.1016\/j.bbapap.2005.08.014_bib76","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/0002-9343(87)90439-6","article-title":"Diagnosis of amyloidosis by abdominal fat aspiration: analysis of four years' experience","volume":"82","author":"Duston","year":"1987","journal-title":"Am. J. Med."},{"key":"10.1016\/j.bbapap.2005.08.014_bib77","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1053\/berh.2000.0089","article-title":"Diagnostic and treatment concerns in familial Mediterranean fever","volume":"14","author":"Livneh","year":"2000","journal-title":"Bailli\u00e8re's Clin. Rheumatol."},{"key":"10.1016\/j.bbapap.2005.08.014_bib78","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1159\/000167653","article-title":"Unsuitable value of abdominal fat tissue aspirate examination for the diagnosis of amyloidosis in long-term hemodialysis patients","volume":"8","author":"Orfila","year":"1988","journal-title":"Am. J. Nephrol."},{"key":"10.1016\/j.bbapap.2005.08.014_bib79","series-title":"Amyloid and Amyloidosis 1990, The Proceedings of the VIth International Symposium on Amyloidosis, Oslo","first-page":"801","article-title":"Beta2-microglobulin does not deposit in abdominal fat tissue of long-term hemodialysis patients","author":"Merlini","year":"1990"},{"key":"10.1016\/j.bbapap.2005.08.014_bib80","doi-asserted-by":"crossref","first-page":"1786","DOI":"10.1056\/NEJMoa013354","article-title":"Misdiagnosis of hereditary amyloidosis as AL (primary) amyloidosis","volume":"346","author":"Lachmann","year":"2002","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bbapap.2005.08.014_bib81","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1111\/j.1365-2559.1996.tb01416.x","article-title":"The classification of amyloid deposits in clinicopathological practice","volume":"29","author":"R\u00f6cken","year":"1996","journal-title":"Histopathology"},{"key":"10.1016\/j.bbapap.2005.08.014_bib82","doi-asserted-by":"crossref","first-page":"108","DOI":"10.3109\/13506120208995243","article-title":"Electron and immuno-electron microscopy of abdominal fat identifies and characterizes amyloid fibrils in suspected cardiac amyloidosis","volume":"9","author":"Arbustini","year":"2002","journal-title":"Amyloid"},{"key":"10.1016\/j.bbapap.2005.08.014_bib83","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1515\/CCLM.2001.167","article-title":"The Pavia approach to clinical protein analysis","volume":"39","author":"Merlini","year":"2001","journal-title":"Clin. Chem. Lab. Med."},{"key":"10.1016\/j.bbapap.2005.08.014_bib84","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1093\/clinchem\/47.4.673","article-title":"Highly sensitive, automated immunoassay for immunoglobulin free light chains in serum and urine","volume":"47","author":"Bradwell","year":"2001","journal-title":"Clin. Chem."},{"key":"10.1016\/j.bbapap.2005.08.014_bib85","first-page":"218","article-title":"The degrees of plasma cell clonality and marrow infiltration adversely influence the prognosis of AL amyloidosis patients","volume":"84","author":"Perfetti","year":"1999","journal-title":"Haematologica"},{"key":"10.1016\/j.bbapap.2005.08.014_bib86","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/S0002-9343(01)00774-4","article-title":"Therapeutic advances demand accurate typing of amyloid deposits","volume":"111","author":"Anesi","year":"2001","journal-title":"Am. J. Med."},{"key":"10.1016\/j.bbapap.2005.08.014_bib87","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1056\/NEJM200210103471517","article-title":"Hereditary amyloidosis","volume":"347","author":"Palladini","year":"2002","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bbapap.2005.08.014_bib88","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1046\/j.1365-2141.2003.04433.x","article-title":"Outcome in systemic amyloidosis in relation to changes in concentration of circulating free immunoglobulin light chains following chemotherapy","volume":"122","author":"Lachmann","year":"2003","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.bbapap.2005.08.014_bib89","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1038\/sj.bmt.1704346","article-title":"High-dose intravenous melphalan and autologous stem cell transplantation as initial therapy or following two cycles of oral chemotherapy for the treatment of AL amyloidosis: results of a prospective randomized trial","volume":"33","author":"Sanchorawala","year":"2004","journal-title":"Bone Marrow Transplant."},{"key":"10.1016\/j.bbapap.2005.08.014_bib90","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/S0002-9343(97)89487-9","article-title":"Treatment of 100 patients with primary amyloidosis: a randomized trial of melphalan, prednisone, and colchicine versus colchicine only","volume":"100","author":"Skinner","year":"1996","journal-title":"Am. J. Med."},{"key":"10.1016\/j.bbapap.2005.08.014_bib91","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1056\/NEJM199704243361702","article-title":"A trial of three regimens for primary amyloidosis: colchicine alone, melphalan and prednisone and melphalan, prednisone and colchicine","volume":"336","author":"Kyle","year":"1997","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bbapap.2005.08.014_bib92","doi-asserted-by":"crossref","first-page":"3520","DOI":"10.1182\/blood-2004-05-1924","article-title":"Clinical efficacy of high dose dexamethasone with maintenance dexamethasone\/alpha interferon in patients with primary systemic amyloidosis: results of United States intergroup trial southwest oncology group (SWOG)","volume":"104","author":"Dhodapkar","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.bbapap.2005.08.014_bib93","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1046\/j.1365-2141.2001.02859.x","article-title":"A modified high-dose dexamethasone regimen for primary systemic amyloidosis","volume":"113","author":"Palladini","year":"2001","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.bbapap.2005.08.014_bib94","doi-asserted-by":"crossref","first-page":"2936","DOI":"10.1182\/blood-2003-08-2788","article-title":"The association of melphalan and high-dose dexamethasone is effective and well tolerated in patients with AL (primary) amyloidosis ineligible for stem cell transplantation","volume":"103","author":"Palladini","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.bbapap.2005.08.014_bib95","doi-asserted-by":"crossref","first-page":"2943","DOI":"10.1182\/blood.V96.9.2943","article-title":"Thalidomide and its analogs overcome drug resistance of human multiple myeloma cells to conventional therapy","volume":"96","author":"Hideshima","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.bbapap.2005.08.014_bib96","doi-asserted-by":"crossref","first-page":"2949","DOI":"10.1182\/blood-2004-08-3231","article-title":"The combination of thalidomide and intermediate dose dexamethasone is an effective but toxic treatment for patients with primary amyloidosis (AL)","volume":"105","author":"Palladini","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.bbapap.2005.08.014_bib97","doi-asserted-by":"crossref","first-page":"24","DOI":"10.3109\/13506120209072441","article-title":"A multicenter phase II trial of 4\u2032-iodo-4\u2032-deoxydoxorubicin in primary amyloidosis (AL)","volume":"9","author":"Gertz","year":"2002","journal-title":"Amyloid"},{"key":"10.1016\/j.bbapap.2005.08.014_bib98","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1182\/blood.V86.3.855.855","article-title":"New drug therapy of amyloidoses: resorption of AL-type deposits with 4\u2032-iodo-4\u2032-deoxydoxorubicin","volume":"86","author":"Gianni","year":"1995","journal-title":"Blood"},{"key":"10.1016\/j.bbapap.2005.08.014_bib99","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1053\/j.arrt.2003.11.003","article-title":"Beta-2 microglobulin in ESRD: an in-depth review","volume":"10","author":"Winchester","year":"2003","journal-title":"Adv. Renal Replace Ther."},{"key":"10.1016\/j.bbapap.2005.08.014_bib100","doi-asserted-by":"crossref","first-page":"2571","DOI":"10.1002\/art.10581","article-title":"Rapid and complete resolution of proteinuria due to renal amyloidosis in a patient with rheumatoid arthritis treated with infliximab","volume":"46","author":"Elkayam","year":"2002","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.bbapap.2005.08.014_bib101","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.1002\/art.11163","article-title":"Anti-Tumor Necrosis Factor alpha therapy in fifteen patients with AA amyloidosis secondary to inflammatory arthritides","volume":"48","author":"Guttemberg","year":"2003","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.bbapap.2005.08.014_bib102","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1093\/rheumatology\/keh357","article-title":"Treatment of renal amyloidosis with etanercept in tumour necrosis factor receptor-associated periodic syndrome","volume":"43","author":"Drewe","year":"2004","journal-title":"Rheumatology"},{"key":"10.1016\/j.bbapap.2005.08.014_bib103","series-title":"Amyloid and Amyloidosis, The Proceedings of the IXth International Symposium on Amyloidosis, Budapest","first-page":"589","article-title":"GAG mimetics: advance in multiple therapeutic areas","author":"Gervais","year":"2001"},{"key":"10.1016\/j.bbapap.2005.08.014_bib104","article-title":"Long-term safety and efficacy of Fibrillex, an anti-amyloid product, as a treatment for amyloid A (AA) amyloidosis: interim analysis of the open-label extension of the pivotal fast trial","author":"Gorevic","year":"2005"},{"key":"10.1016\/j.bbapap.2005.08.014_bib105","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1097\/01.TP.0000092307.98347.CB","article-title":"Ten years of international experience with liver transplantation for familial amyloidotic polyneuropathy: results from the familial amyloidotic polyneuropathy world transplant registry","volume":"77","author":"Herlenius","year":"2004","journal-title":"Transplantation"},{"key":"10.1016\/j.bbapap.2005.08.014_bib106","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1097\/00019052-200410000-00012","article-title":"Liver transplantation in transthyretin-related familial amyloid polyneuropathy","volume":"17","author":"Stangou","year":"2004","journal-title":"Curr. Opin. Neurol."},{"key":"10.1016\/j.bbapap.2005.08.014_bib107","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1093\/qjmed\/93.5.269","article-title":"Curative hepatorenal transplantation in systemic amyloidosis caused by the Glu526Val fibrinogen alpha-chain variant in an English family","volume":"93","author":"Gillmore","year":"2000","journal-title":"Q.J.M."},{"key":"10.1016\/j.bbapap.2005.08.014_bib108","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1097\/00007890-200104150-00026","article-title":"Clinical and biochemical outcome of hepatorenal transplantation for hereditary systemic amyloidosis associated with apolipoprotein A-I Gly26Arg","volume":"71","author":"Gillmore","year":"2001","journal-title":"Transplantation"},{"key":"10.1016\/j.bbapap.2005.08.014_bib109","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1038\/modpathol.3880353","article-title":"Livers from patients with apolipoprotein A-I amyloidosis are not suitable as \u201cdomino\u201d donors","volume":"14","author":"Shaz","year":"2001","journal-title":"Mod. Pathol."},{"key":"10.1016\/j.bbapap.2005.08.014_bib110","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1046\/j.1523-1755.1998.00770.x","article-title":"Hereditary nephropatic systemic amyloidosis caused by a novel variant apolipoprotein A-I","volume":"53","author":"Persey","year":"1998","journal-title":"Kidney Int."},{"key":"10.1016\/j.bbapap.2005.08.014_bib111","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1016\/j.healun.2003.08.027","article-title":"Cardiac transplantation for amyloid heart disease: the United Kingdom experience","volume":"23","author":"Dubrey","year":"2004","journal-title":"J. Heart Lung Transplant."},{"key":"10.1016\/j.bbapap.2005.08.014_bib112","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1038\/nm0798-822","article-title":"Beta-sheet breaker peptides inhibit fibrillogenesis in a rat brain model of amyloidosis: implications for Alzheimer's therapy","volume":"4","author":"Soto","year":"1998","journal-title":"Nat. Med."},{"key":"10.1016\/j.bbapap.2005.08.014_bib113","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1007\/0-387-23226-5_18","article-title":"Amyloid inhibitors and beta-sheet breakers","volume":"38","author":"Soto","year":"2005","journal-title":"Subcell. Biochem."},{"key":"10.1016\/j.bbapap.2005.08.014_bib114","doi-asserted-by":"crossref","first-page":"4109","DOI":"10.1073\/pnas.94.8.4109","article-title":"Disaggregation of Alzheimer \u03b2-amyloid by site-directed mAb","volume":"94","author":"Solomon","year":"1997","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.bbapap.2005.08.014_bib115","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1016\/S0002-9440(10)64639-1","article-title":"Antibody-mediated resolution of light chain-associated amyloid deposits","volume":"157","author":"Hrncic","year":"2000","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.bbapap.2005.08.014_bib116","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1038\/417254a","article-title":"Targeted pharmacological depletion of serum amyloid P component for treatment of human amyloidosis","volume":"417","author":"Pepys","year":"2002","journal-title":"Nature"}],"container-title":["Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1570963905002815?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1570963905002815?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,4,9]],"date-time":"2020-04-09T04:16:34Z","timestamp":1586405794000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1570963905002815"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,11]]},"references-count":116,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2005,11]]}},"alternative-id":["S1570963905002815"],"URL":"https:\/\/doi.org\/10.1016\/j.bbapap.2005.08.014","relation":{},"ISSN":["1570-9639"],"issn-type":[{"value":"1570-9639","type":"print"}],"subject":[],"published":{"date-parts":[[2005,11]]}}}